We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MLYS market cap is 627.06M. The company's latest EPS is USD -1.4481 and P/E is -8.71.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.94M | -15.74M | -26.27M | -27.71M | -35.36M |
| Net Income | -12.61M | -12.14M | -22.76M | -24.39M | -31.51M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -2.94M | -18.73M | -31.48M | -84.66M |
| Net Income | -3.43M | -19.41M | -29.8M | -71.9M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 306.44M | 291.22M | 277.56M | 251.64M | 347.25M |
| Total Liabilities | 10.56M | 6.21M | 13.54M | 10.48M | 19.2M |
| Total Equity | 295.88M | 285.01M | 264.01M | 241.15M | 328.05M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.49M | 11.13M | 114.44M | 251.64M |
| Total Liabilities | 5.08M | 5.05M | 8.07M | 10.48M |
| Total Equity | -3.6M | -22.93M | -52.27M | 241.15M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -12.78M | -33.16M | -52.19M | -81.17M | -19.14M |
| Investing | -140.25M | -156.39M | -152.38M | -160.47M | -55.95M |
| Financing | 203.57M | 202.99M | 203.17M | 203.25M | 116.21M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.46M | -14.56M | -29.22M | -81.17M |
| Investing | N/A | N/A | -21.76M | -160.47M |
| Financing | 3.83M | 23.81M | 128.02M | 203.25M |
| Market Cap | 627.06M |
| Price to Earnings Ratio | -8.71 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 12.71 |
| Price to Book Ratio | 2.6 |
| Dividend Yield | - |
| Shares Outstanding | 49.65M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 1 (7.52%) |
| Company Name | Mineralys Therapeutics Inc |
| Address |
corporation trust center 1209 orange street wilmington, delaware 19801 |
| Website | https://www.mineralystx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
